EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

κ-opioid receptor: from analgesic target to neuroimmune hub

Qinsi Tan, Mengjin Zheng, Huaixin Xing

Frontiers in Pharmacology · 07.01.2026 · 16

DOI: 10.3389/fphar.2025.1744231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.01.2026. Verfasst von Qinsi Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Medical Award Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Originally characterized as a classical mediator of analgesia, the κ-opioid receptor (KOR) has recently emerged as a pivotal regulator at the crossroads of the nervous and immune systems. Beyond its canonical role in nociceptive processing, a growing body of evidence reveals that KOR exerts profound immunomodulatory effects. The receptor is broadly expressed across diverse immune cell populations, including macrophages, microglia, and lymphocytes, where it contributes to immune homeostasis by attenuating the activity of key pro-inflammatory transcription factors, notably nuclear factor κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3). These regulatory effects are mediated through both canonical G protein–coupled (Gαi/o) pathways and non-canonical β-arrestin–dependent cascades. Preclinical investigations have demonstrated that pharmacological modulation of KOR confers significant therapeutic benefits in a range of immune-related disorders, including atopic dermatitis, multiple sclerosis, and osteoarthritis. However, the clinical translation of traditional KOR agonists remains limited by dose-dependent central nervous system (CNS) adverse effects, such as dysphoria and hallucinations. In this review, we synthesize recent advances in elucidating the molecular and cellular mechanisms underlying KOR-mediated immunoregulation, highlight its therapeutic potential across diverse neuroimmune pathologies, and discuss innovative pharmacological strategies, such as peripherally restricted and signaling-biased ligands-designed to preserve beneficial immunomodulatory and analgesic properties while minimizing CNS liabilities. Collectively, these insights redefine KOR as a central node in neuroimmune communication and point toward the development of next-generation precision therapeutics targeting this axis.

Schlagwörter

Stichwörter der Autor:innen

biasedagonismimmune cellsneuroimmunomodulationsignal transductiontherapeutic targetκ-opioid receptor (KOR)

Autor:innen und Institutionen

  • Graduate School of Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Anesthesiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Förderung

  • Beijing Medical Award Foundation

Zitieren

APA

Tan, Q., Zheng, M., & Xing, H. (2026). κ-opioid receptor: from analgesic target to neuroimmune hub. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1744231

Vancouver

Tan Q, Zheng M, Xing H. κ-opioid receptor: from analgesic target to neuroimmune hub. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1744231

BibTeX
@article{Tan2026,
  author = {Tan, Qinsi and Zheng, Mengjin and Xing, Huaixin},
  title = {κ-opioid receptor: from analgesic target to neuroimmune hub},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fphar.2025.1744231}
}
Kostenlos starten →